Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Rocconi, Rodney P
GOG-3039, NCT04393285: Abemaciclib and Letrozole to Treat Endometrial Cancer	Active, not recruiting	2	53	US	Abemaciclib, Letrozole	Gynecologic Oncology Group, Eli Lilly and Company	Endometrial Cancer	12/24	12/25
NCT05051722: Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer	Recruiting	2	2640	US	Tampon Collection, Vaginal Fluid, Blood Collection	Mayo Clinic	Endometrial Cancer, Cervical Cancer, Atypical Endometrial Hyperplasia, Cervical Dysplasia, Adnexal Mass, Ovarian Cancer	06/25	12/25
NCT01198171: Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer	Not yet recruiting	N/A	243	US	Laboratory Biomarker Analysis, Study of Socioeconomic and Demographic Variables	Gynecologic Oncology Group, National Cancer Institute (NCI)	Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer	01/00